When your appetite is suppressed and you are eating 1,200 to 1,500 calories per day, getting that much protein from food alone is extremely difficult
Study findings revealed that an alarming 73.8% of patients suffered from at least one obesity-associated comorbidity, while 51.0% had two or more obesity-related complications
This additional mechanism has become one of the defining features of retatrutide research and is a major reason the peptide has attracted significant attention within obesity, metabolic health, and weight management studies
For comparison, in the table below, we also show those GLP-1 agonists with active ingredients only approved for treatment of diabetes that have less potential for off-label weight loss use (Bydureon BCise, Trulicity)
It is clinician-led and prescribes only FDA-approved GLP-1 medications alongside required baseline labs, ongoing medical oversight, and a structured lifestyle curriculum